Cosmos Health Inc.
General ticker "COSM" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $20.1M (TTM average)
Cosmos Health Inc. does not follow the US Stock Market performance with the rate: -24.0%.
Estimated limits based on current volatility of 8.8%: low 0.25$, high 0.30$
Factors to consider:
- Total employees count: 163 (+9.4%) as of 2025
- Top business risk factors: Capital constraints, Currency fluctuations, Geopolitical risks, Cybersecurity threats, Regulatory and compliance
- Current price 29.3% below estimated low
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.33$, 0.98$]
- 2026-12-31 to 2027-12-31 estimated range: [0.26$, 0.80$]
Financial Metrics affecting the COSM estimates:
- Positive: with PPE of -0.9 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Positive: Industry inventory ratio change (median), % of 0.12 <= 0.28
- Negative: negative Operating income
- Positive: Inventory ratio change, % of 0.72 <= 0.80
- Positive: -14.27 < Investing cash flow per share per price, % of -13.09
Short-term COSM quotes
Long-term COSM plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $53.38MM | $54.43MM | $65.27MM |
| Operating Expenses | $75.21MM | $69.97MM | $81.98MM |
| Operating Income | $-21.83MM | $-15.54MM | $-16.70MM |
| Non-Operating Income | $3.29MM | $-0.64MM | $-2.44MM |
| Interest Expense | $0.87MM | $1.01MM | $1.90MM |
| R&D Expense | $0.00MM | $0.53MM | $0.52MM |
| Income(Loss) | $-18.54MM | $-16.18MM | $-19.14MM |
| Net Income(Loss)* | $-18.54MM | $-16.18MM | $-19.14MM |
| Stockholders Equity | $36.04MM | $24.53MM | $-0.92MM |
| Inventory | $4.79MM | $4.36MM | $5.78MM |
| Assets | $66.01MM | $54.31MM | $65.48MM |
| Operating Cash Flow | $-15.64MM | $-7.72MM | $-8.45MM |
| Capital expenditure | $9.17MM | $0.42MM | $0.06MM |
| Investing Cash Flow | $-13.76MM | $-0.80MM | $-2.01MM |
| Financing Cash Flow | $12.69MM | $5.05MM | $14.06MM |
| Earnings Per Share** | $-1.55 | $-0.85 | $-0.63 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.